Chronic Obstructive Pulmonary Disease (COPD) is a serious disease that places a heavy burden on affected patients and the healthcare system. Consequently, there are two Pharmacotherapy management measures related to COPD exacerbation for HEDIS Measurement Year 2020 (MY 2020).1 COPD is a group of lung conditions that include emphysema, chronic bronchitis and sometimes asthma. Symptoms of COPD include shortness of breath, cough and sputum production. Exposure to tobacco smoke or air pollutants usually damages the lungs and leads to COPD. Often, COPD patients develop breathing difficulties that become severely worse, known as exacerbations. Serious exacerbations can lead to hospitalization, decreased lung function and possibly death.